PUBLIC RESEARCH DOSSIER
LLY · NYSEELI LILLY & Co
Manufacturing · Pharmaceutical PreparationsCompleted-session closeUS$1,409.38-0.11%Price as of 2026-11-03 · Not real-time
Eli Lilly and Company (LLY) discovers, develops, manufactures and markets human pharmaceutical products in one reportable segment. Its portfolio includes Mounjaro and Zepbound; development, capacity, approvals and payer access shape availability.
This public dossier summarizes published prices, valuation, risk, financials and peer comparisons for 礼来 (LLY). Price data as of 2026-11-03; not real-time. Missing values are not treated as zero.
Share price history
Adjusted close (USD)
2025-10-31 — 2026-11-03253 trading-day observations
LLYUS$1,409.38
View chart data
| Date | LLY |
|---|---|
| 2025-10-31 | 857.43 |
| 2025-11-03 | 890.89 |
| 2025-11-04 | 901.16 |
| 2025-11-05 | 919.99 |
| 2025-11-06 | 931.54 |
| 2025-11-07 | 918.56 |
| 2025-11-10 | 960.56 |
| 2025-11-11 | 982.4 |
| 2025-11-12 | 1,011.38 |
| 2025-11-13 | 1,016.44 |
| 2025-11-14 | 1,020.32 |
| 2025-11-17 | 1,016.76 |
| 2025-11-18 | 1,025.07 |
| 2025-11-19 | 1,044.52 |
| 2025-11-20 | 1,038.25 |
| 2025-11-21 | 1,054.58 |
| 2025-11-24 | 1,064.99 |
| 2025-11-25 | 1,104.57 |
| 2025-11-26 | 1,099 |
| 2025-11-28 | 1,070.27 |
| 2025-12-01 | 1,052.77 |
| 2025-12-02 | 1,041.06 |
| 2025-12-03 | 1,028.56 |
| 2025-12-04 | 1,009.58 |
| 2025-12-05 | 1,005.42 |
| 2025-12-08 | 992.77 |
| 2025-12-09 | 977.47 |
| 2025-12-10 | 988.84 |
| 2025-12-11 | 1,004.5 |
| 2025-12-12 | 1,022.54 |
| 2025-12-15 | 1,057.05 |
| 2025-12-16 | 1,049.19 |
| 2025-12-17 | 1,036.75 |
| 2025-12-18 | 1,051.77 |
| 2025-12-19 | 1,066.26 |
| 2025-12-22 | 1,071.27 |
| 2025-12-23 | 1,066.46 |
| 2025-12-24 | 1,071.77 |
| 2025-12-26 | 1,072.54 |
| 2025-12-29 | 1,073.51 |
| 2025-12-30 | 1,074.53 |
| 2025-12-31 | 1,069.48 |
| 2026-01-02 | 1,075.14 |
| 2026-01-05 | 1,036.47 |
| 2026-01-06 | 1,058.9 |
| 2026-01-07 | 1,102.73 |
| 2026-01-08 | 1,079.94 |
| 2026-01-09 | 1,058.42 |
| 2026-01-12 | 1,075.77 |
| 2026-01-13 | 1,071.98 |
| 2026-01-14 | 1,068.1 |
| 2026-01-15 | 1,027.98 |
| 2026-01-16 | 1,033.38 |
| 2026-01-20 | 1,036.26 |
| 2026-01-21 | 1,073.31 |
| 2026-01-22 | 1,082.12 |
| 2026-01-23 | 1,059.14 |
| 2026-01-26 | 1,057.61 |
| 2026-01-27 | 1,034.48 |
| 2026-01-28 | 1,018.85 |
| 2026-01-29 | 1,019.19 |
| 2026-01-30 | 1,032.14 |
| 2026-02-02 | 1,039.08 |
| 2026-02-03 | 998.61 |
| 2026-02-04 | 1,101.77 |
| 2026-02-05 | 1,015.9 |
| 2026-02-06 | 1,053.06 |
| 2026-02-09 | 1,039.62 |
| 2026-02-10 | 1,020.04 |
| 2026-02-11 | 1,010.3 |
| 2026-02-12 | 1,033.25 |
| 2026-02-13 | 1,036.69 |
| 2026-02-17 | 1,032.76 |
| 2026-02-18 | 1,017.31 |
| 2026-02-19 | 1,019.97 |
| 2026-02-20 | 1,006.31 |
| 2026-02-23 | 1,055.19 |
| 2026-02-24 | 1,038.84 |
| 2026-02-25 | 1,025.56 |
| 2026-02-26 | 1,018.77 |
| 2026-02-27 | 1,048.64 |
| 2026-03-02 | 1,014.73 |
| 2026-03-03 | 1,004.53 |
| 2026-03-04 | 1,000.38 |
| 2026-03-05 | 980.13 |
| 2026-03-06 | 987.18 |
| 2026-03-09 | 1,005.18 |
| 2026-03-10 | 998.17 |
| 2026-03-11 | 996.66 |
| 2026-03-12 | 974.14 |
| 2026-03-13 | 981.95 |
| 2026-03-16 | 985.97 |
| 2026-03-17 | 927.39 |
| 2026-03-18 | 915.13 |
| 2026-03-19 | 914.58 |
| 2026-03-20 | 903.82 |
| 2026-03-23 | 907.65 |
| 2026-03-24 | 900.15 |
| 2026-03-25 | 913.4 |
| 2026-03-26 | 894.15 |
| 2026-03-27 | 875.45 |
| 2026-03-30 | 883.81 |
| 2026-03-31 | 916.85 |
| 2026-04-01 | 951.48 |
| 2026-04-02 | 932.61 |
| 2026-04-06 | 924.11 |
| 2026-04-07 | 928.13 |
| 2026-04-08 | 950.27 |
| 2026-04-09 | 952.15 |
| 2026-04-10 | 936.48 |
| 2026-04-13 | 926.59 |
| 2026-04-14 | 919.57 |
| 2026-04-15 | 902.15 |
| 2026-04-16 | 901.12 |
| 2026-04-17 | 924.08 |
| 2026-04-20 | 916.97 |
| 2026-04-21 | 900.15 |
| 2026-04-22 | 918.55 |
| 2026-04-23 | 914.73 |
| 2026-04-24 | 881.15 |
| 2026-04-27 | 865.51 |
| 2026-04-28 | 871.22 |
| 2026-04-29 | 848.5 |
| 2026-04-30 | 931.63 |
| 2026-05-01 | 960.27 |
| 2026-05-04 | 964.85 |
| 2026-05-05 | 985.73 |
| 2026-05-06 | 983.91 |
| 2026-05-07 | 971.86 |
| 2026-05-08 | 945.43 |
| 2026-05-11 | 963.92 |
| 2026-05-12 | 986.72 |
| 2026-05-13 | 1,012.52 |
| 2026-05-14 | 1,003.5 |
| 2026-05-15 | 1,003.45 |
| 2026-05-18 | 986.64 |
| 2026-05-19 | 1,019.91 |
| 2026-05-20 | 1,017.38 |
| 2026-05-21 | 1,040.13 |
| 2026-05-22 | 1,063.44 |
| 2026-05-26 | 1,063.18 |
| 2026-05-27 | 1,081.33 |
| 2026-05-28 | 1,125.15 |
| 2026-05-29 | 1,103.38 |
| 2026-06-01 | 1,080.62 |
| 2026-06-02 | 1,062.59 |
| 2026-06-03 | 1,077.2 |
| 2026-06-04 | 1,123.62 |
| 2026-06-05 | 1,129.76 |
| 2026-06-08 | 1,147.47 |
| 2026-06-09 | 1,143 |
| 2026-06-10 | 1,134.71 |
| 2026-06-11 | 1,159.25 |
| 2026-06-12 | 1,131.34 |
| 2026-06-15 | 1,127.7 |
| 2026-06-16 | 1,120.86 |
| 2026-06-17 | 1,110.37 |
| 2026-06-18 | 1,096.96 |
| 2026-06-22 | 1,100.47 |
| 2026-06-23 | 1,105.46 |
| 2026-06-24 | 1,115.62 |
| 2026-06-25 | 1,126.04 |
| 2026-06-26 | 1,206.35 |
| 2026-06-29 | 1,228.13 |
| 2026-06-30 | 1,197.67 |
| 2026-07-01 | 1,190 |
| 2026-07-02 | 1,212.13 |
| 2026-07-06 | 1,198.3 |
| 2026-07-07 | 1,233.75 |
| 2026-07-08 | 1,214.05 |
| 2026-07-09 | 1,215.17 |
| 2026-07-10 | 1,186.84 |
| 2026-07-13 | 1,180.14 |
| 2026-07-14 | 1,150.85 |
| 2026-07-15 | 1,154.94 |
| 2026-07-16 | 1,167.46 |
| 2026-07-17 | 1,177.38 |
| 2026-07-20 | 1,145.22 |
| 2026-07-21 | 1,173.69 |
| 2026-07-22 | 1,161.31 |
| 2026-07-23 | 1,184.13 |
| 2026-07-24 | 1,194.28 |
| 2026-07-27 | 1,195.78 |
| 2026-07-28 | 1,218.87 |
| 2026-07-29 | 1,208.25 |
| 2026-07-30 | 1,153.28 |
| 2026-07-31 | 1,147.16 |
| 2026-08-03 | 1,119.72 |
| 2026-08-04 | 1,114.05 |
| 2026-08-05 | 1,168.15 |
| 2026-08-06 | 1,190.2 |
| 2026-08-07 | 1,183.97 |
| 2026-08-10 | 1,230.14 |
| 2026-08-11 | 1,213.24 |
| 2026-08-12 | 1,218.49 |
| 2026-08-13 | 1,207.23 |
| 2026-08-14 | 1,180.16 |
| 2026-08-17 | 1,183.16 |
| 2026-08-18 | 1,225.73 |
| 2026-08-19 | 1,280.34 |
| 2026-08-20 | 1,244.4 |
| 2026-08-21 | 1,255.4 |
| 2026-08-24 | 1,246.93 |
| 2026-08-25 | 1,233.66 |
| 2026-08-26 | 1,189.41 |
| 2026-08-27 | 1,176.1 |
| 2026-08-28 | 1,174.61 |
| 2026-08-31 | 1,156.73 |
| 2026-09-01 | 1,160 |
| 2026-09-02 | 1,160.08 |
| 2026-09-03 | 1,159.6 |
| 2026-09-04 | 1,149.36 |
| 2026-09-08 | 1,123.91 |
| 2026-09-09 | 1,124.21 |
| 2026-09-10 | 1,123 |
| 2026-09-11 | 1,115.7 |
| 2026-09-14 | 1,138.28 |
| 2026-09-15 | 1,136.11 |
| 2026-09-16 | 1,137.82 |
| 2026-09-17 | 1,152.44 |
| 2026-09-18 | 1,152.93 |
| 2026-09-21 | 1,164.89 |
| 2026-09-22 | 1,170.14 |
| 2026-09-23 | 1,150.99 |
| 2026-09-24 | 1,181.89 |
| 2026-09-25 | 1,183.46 |
| 2026-09-28 | 1,184.78 |
| 2026-09-29 | 1,184.63 |
| 2026-09-30 | 1,157.08 |
| 2026-10-01 | 1,149.85 |
| 2026-10-02 | 1,142.85 |
| 2026-10-05 | 1,143.12 |
| 2026-10-06 | 1,157.49 |
| 2026-10-07 | 1,188.72 |
| 2026-10-08 | 1,169.6 |
| 2026-10-09 | 1,179.27 |
| 2026-10-12 | 1,182.62 |
| 2026-10-13 | 1,166.51 |
| 2026-10-14 | 1,208.74 |
| 2026-10-15 | 1,251.61 |
| 2026-10-16 | 1,257.03 |
| 2026-10-19 | 1,240.34 |
| 2026-10-20 | 1,283.66 |
| 2026-10-21 | 1,270.75 |
| 2026-10-22 | 1,306.69 |
| 2026-10-23 | 1,273.46 |
| 2026-10-26 | 1,279.14 |
| 2026-10-27 | 1,281.91 |
| 2026-10-28 | 1,288.3 |
| 2026-10-29 | 1,373.7 |
| 2026-10-30 | 1,417.54 |
| 2026-11-02 | 1,410.99 |
| 2026-11-03 | 1,409.38 |
The 1, 3, 6 and 12 month ranges use 21, 63, 126 and 252 trading sessions respectively. Missing dates are not replaced with dates outside the range.
Uses existing daily adjusted closing prices, not live quotes. Chart values may differ from unadjusted closing quotes.
01 · MARKET FRAME
Price, valuation & risk
Based on completed sessions and published financial records
Period returns
Period returns use adjusted closes. Missing valuation and risk metrics display as —, never as zero.
02 · FINANCIAL TRACE
Financial summary
Public pages show only the latest three validated reporting periods
Annual financial trends
USD millions · Annual reporting periods
Revenue65,179USD millions
| Metric | 2026-08-03 | 2026-06-30 | 2025-12-31 | 2025-08-04 | 2025-06-30 | 2024-12-31 | 2024-08-05 | 2024-06-30 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 65,179 | — | — | 45,043 | — | — | 34,124 |
| Net income | — | — | 20,640 | — | — | 10,590 | — | — | 5,240 |
| Free cash flow | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 941.4 | — | — | 946.5 | — | — | 950.4 | — | — |
| Debt | — | — | — | — | — | — | — | — | — |
| Total assets | — | 142,283 | — | — | 100,922.6 | — | — | 71,874.8 | — |
Reported revenue basis
Amounts and share counts are in millions. Missing or unverified data is not treated as zero.
03 · PEER SET
Peer comparison
Closest market-cap peers in the same industry
| Company | Market cap | 250-day return | P/E | Distance from 52-week high | Volatility |
|---|---|---|---|---|---|
| JNJ强生 | US$640.8B | +45.7% | 30.5× | -4.4% | +20.7% |
| ABBV艾伯维 | US$505.4B | +35.6% | 80.1× | -3% | +25.4% |
| MRK默沙东 | US$356.9B | +76.6% | 112.5× | -7.5% | +30.1% |
| NVS诺华制药 | US$303.9B | +31.3% | — | -2.7% | +26.7% |
Peers use covered-company classifications and market-cap proximity for comparison only. Missing values are not treated as zero.